squares regression (Malvern Panalytical)
Malvern Panalytical is a verified supplier 
Malvern Panalytical manufactures this product 
86
Structured Review
Malvern Panalytical
squares regression
Squares Regression, supplied by Malvern Panalytical, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/squares+regression/pm41713101-116-18-23
Average 86 stars, based on 1 article reviews
Squares Regression, supplied by Malvern Panalytical, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/squares+regression/pm41713101-116-18-23
Average 86 stars, based on 1 article reviews
squares regression - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
other:Article Title: The pentapeptide QYNAD does not inhibit neuronal network activity. Article Snippet: Injection:Article Title: Repurposing amide-based drugs unveils inhibition mechanisms of plasmodium falciparum Plasmepsin V enzymatic activity for antimalarial therapy. Article Snippet: Understanding how enzymes are inhibited at the molecular level is essential for rational drug design against malaria parasites.. Plasmodium falciparum Plasmepsin V (PfPlmV), an aspartic protease essential for exporting parasite proteins into host red blood cells has emerged as potent target for anti-malarial therapy.. In this work, we investigated whether three approved amide-based drugs favipiravir, 5-fluorouracil (5-FU), and saquinavir could inhibit catalytic activity of PfPlmV. Binding Assay:Article Title: Repurposing amide-based drugs unveils inhibition mechanisms of plasmodium falciparum Plasmepsin V enzymatic activity for antimalarial therapy. Article Snippet: Understanding how enzymes are inhibited at the molecular level is essential for rational drug design against malaria parasites.. Plasmodium falciparum Plasmepsin V (PfPlmV), an aspartic protease essential for exporting parasite proteins into host red blood cells has emerged as potent target for anti-malarial therapy.. In this work, we investigated whether three approved amide-based drugs favipiravir, 5-fluorouracil (5-FU), and saquinavir could inhibit catalytic activity of PfPlmV. |